TWD
IRWD icon

True Wealth Design’s Ironwood Pharmaceuticals IRWD Stock Holding History

True Wealth Design’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$10.1K Buy
2,390
+29
+1% +$112 ﹤0.01% 1054
2026
Q1 		$8.29K Hold
2,361
– – ﹤0.01% 1038
2025
Q4 		$7.96K Hold
2,361
– – ﹤0.01% 933
2025
Q3 		$3.09K Buy
2,361
+1,343
+132% +$1.39K ﹤0.01% 1297
2025
Q2 		$731 Buy
1,018
+897
+741% +$704 ﹤0.01% 1593
2025
Q1 		$178 Buy
+121
New +$288 ﹤0.01% 2002
2024
Q4 		– Sell
-112
Closed -$462 – 1440
2024
Q3 		$462 Buy
+112
New +$602 ﹤0.01% 1113

Other funds holding IRWD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $178M AUM 118.43% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

True Wealth Design's IRWD Position: Q2 2026 in Review

True Wealth Design increased its Ironwood Pharmaceuticals (IRWD) stake by 1.2% in Q2 2026, buying an estimated $112 and bringing the position to 2,390 shares worth $10.1K. The position accounts for ﹤0.01% of the portfolio, ranked #1054.

True Wealth Design first reported a position in IRWD in Q3 2024 and has held it in 7 quarters since. 212 funds tracked by Wall St. Rank hold IRWD as of Q2 2026.

  • True Wealth Design held 2,390 shares of Ironwood Pharmaceuticals worth $10.1K as of Q2 2026.
  • True Wealth Design bought 29 Ironwood Pharmaceuticals shares in Q2 2026, an estimated $112.
  • Ironwood Pharmaceuticals made up ﹤0.01% of True Wealth Design's portfolio in Q2 2026, its #1054 holding.
  • True Wealth Design first reported a position in Ironwood Pharmaceuticals in Q3 2024 and has held it in 7 quarters since.
  • 212 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q2 2026.

Based on True Wealth Design's 13F filing for Q2 2026, filed 16 Jul 2026.